China, Nov. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'MRI-Based Multi-Task Deep Learning for Pancreatic Ductal Adenocarcinoma Segmentation, Localization, and Pathological TNM Staging Prediction'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600137191

Registration Time: 2026/11/19

Type: Observational study

Primary Sponsor: Huzhou Center Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350896

Published by HT Digital Content Services with permission from Health Daily Digest....